Targets and strategies for vaccine development against SARS-CoV-2

Vaxign-ML: Supervised Machine Learning Reverse Vaccinology Model for Improved Prediction of Bacterial Protective Antigens

(2020) Edison Ong et al.   BIOINFORMATICS

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

(2020) Jasper Fuk-Woo Chan et al.   LANCET

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

(2020) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progress and Concept for COVID‐19 Vaccine Development

(2020) Suh‐Chin Wu   Biotechnology Journal

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

(2020) Wanbo Tai et al.   Cellular & Molecular Immunology

SARS-CoV-2 Vaccines: Status Report

(2020) Fatima Amanat et al.   IMMUNITY

Deployment of convalescent plasma for the prevention and treatment of COVID-19

(2020) Evan M. Bloch et al.   JOURNAL OF CLINICAL INVESTIGATION

Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19

(2020) Bruno Tilocca et al.   MICROBES AND INFECTION

Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees

(2020) Shibo Jiang   NATURE

Could BCG be used to protect against COVID-19?

(2020) Gil Redelman-Sidi   Nature Reviews Urology

Developing a vaccine for covid-19

(2020) Sarah Caddy   BMJ-British Medical Journal

Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach

(2020) Miyssa I. Abdelmageed et al.   Biomed Research International

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

(2020) Sisi Kang et al.   Acta Pharmaceutica Sinica B

Progress and Prospects on Vaccine Development against SARS-CoV-2

(2020) Jinyong Zhang et al.   Vaccines

Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials

(2020) Bijayeeta Deb et al.   JOURNAL OF BIOSCIENCES

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

(2020) Giovanni Salvatori et al.   Journal of Translational Medicine

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

Coronavirus vaccines get a biotech boost

(2020) Amber Dance   NATURE

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

(2020) Neeltje van Doremalen et al.   NATURE

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

(2020) Ann M. Arvin et al.   NATURE

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID ‐19

(2020) B. Linju Yen et al.   Stem Cells Translational Medicine

Vaccination strategies to combat novel corona virus SARS-CoV-2

(2020) Satish Chandra Pandey et al.   LIFE SCIENCES

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship

(2020) Öner Özdemir   mBio

Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Commentary: Clinical Applications of Virus-like Particles: Opportunities and Challenges

(2019) Kun Huang et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Non-specific effects of BCG vaccine on viral infections

(2019) S.J.C.F.M. Moorlag et al.   CLINICAL MICROBIOLOGY AND INFECTION

Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

(2019) Charles Vragniau et al.   Science Advances

Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention

(2019) Pedro L. Moro et al.   Expert Review of Vaccines

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Development of novel vaccine vectors: Chimpanzee adenoviral vectors

(2018) Jingao Guo et al.   Human Vaccines & Immunotherapeutics

Why are RNA virus mutation rates so damn high?

(2018) Siobain Duffy   PLOS BIOLOGY

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

(2016) Anurodh Shankar Agrawal et al.   Human Vaccines & Immunotherapeutics

Recent advances in the production of recombinant subunit vaccines inPichia pastoris

(2016) Man Wang et al.   Bioengineered

Live attenuated vaccines: Historical successes and current challenges

(2015) Philip D. Minor   VIROLOGY

A structural analysis of M protein in coronavirus assembly and morphology

(2010) Benjamin W. Neuman et al.   JOURNAL OF STRUCTURAL BIOLOGY